SCHEMBL12729558

SCHEMBL12729558

CC(C)[Si]1(C(C)C)OCC2OC(n3ccc(=O)n(C(=O)CCCSSc4ccccn4)c3=O)CC2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12531469 0.78 POLB (0.34) —
SCHEMBL12729559 0.77 DNMT1 (0.37) —
SCHEMBL17833865 0.75 POLB (0.35) —
SCHEMBL12729592 0.70 HDAC1 (0.37) —
SCHEMBL12729560 0.70 P2RY2 (0.41) —
SCHEMBL12729571 0.70 ADORA3 (0.33) —
SCHEMBL12729601 0.70 KDM4E (0.39) —
SCHEMBL12531609 0.65 LMNA (0.40) —
SCHEMBL16503451 0.64 DUT (0.36) —
SCHEMBL1592652 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160168636-A1 NUCLEOTIDE ANALOGS HELICOS BIOSCIENCES CORPORATION 2016-06-16 — — US disclosed
US-20160168636-A1 NUCLEOTIDE ANALOGS HELICOS BIOSCIENCES CORPORATION 2016-06-16 — — US disclosed
US-9163053-B2 Nucleotide analogs FLUIDIGM CORPORATION (US) 2015-10-20 — — US disclosed
US-9163053-B2 Nucleotide analogs FLUIDIGM CORPORATION (US) 2015-10-20 — — US disclosed
US-20110081647-A1 NUCLEOTIDE ANALOGS HELICOS BIOSCIENCES CORPORATION (US) 2011-04-07 — — US disclosed
Send feedback